Everything You Need to Know About Paxlovid

Hopes that it could be useful for treating people with mild illness have also proved unfounded. In June, a trial of Paxlovid’s effects in standard-risk Covid patients was ended when the treatment failed to significantly relieve the symptoms of those participating.

Paxlovid’s usefulness is in protecting at-risk people from experiencing the very worst effects of Covid—it isn’t used to stop people from developing symptoms altogether, nor to block an infection after someone has been exposed.

Does It Work Against the Newer Variants?

It appears so. In February 2022, Pfizer reported that nirmatrelvir was effective in halting

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

3 Steps to Web3: The Ultimate Guide to Navigating Web3 for Non-Tech Founders

Opinions expressed by Entrepreneur contributors are their own. Now that we're well over halfway through 2022, it's safe to say there's definitely...

13 Ways to Grow Omnichannel Customer Engagement

Opinions expressed by Entrepreneur contributors are their own. Omnichannel customer engagement is no longer a nice-to-have — it's a necessity. In today's...

A Good Story Isn't Enough to Get Your Startup Funded. Here's What Else You Need.

Opinions expressed by Entrepreneur contributors are their own. There is a growing sense among founders in the global tech startup scene, and...